Market Overview:  The myelodysplastic syndrome market reached a value of US$ 2.3 Billion in 2023 and expected to reach US$ 4.5 Billion by 2034, exhibiting a growth rate (CAGR) of 6.25% during 2024-2034. The myelodysplastic syndrome market report offers a comprehensive analysis of the market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and...